These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2813664

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FDA's position on the clozaril patient management system.
    Peck CC.
    Hosp Community Psychiatry; 1990 Aug; 41(8):876-7. PubMed ID: 2401475
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA.
    N Engl J Med; 1993 Jul 15; 329(3):162-7. PubMed ID: 8515788
    [Abstract] [Full Text] [Related]

  • 6. Do white-cell count spikes predict agranulocytosis in clozapine recipients?
    Alvir JM, Lieberman JA, Safferman AZ.
    Psychopharmacol Bull; 1995 Jul 15; 31(2):311-4. PubMed ID: 7491384
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clozapine treatment in Australia: a review of haematological monitoring.
    Copolov DL, Bell WR, Benson WJ, Keks NA, Strazzeri DC, Johnson GF.
    Med J Aust; 1998 May 18; 168(10):495-7. PubMed ID: 9631674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hematological complications caused by clozapine (Leponex)].
    Palva I.
    Duodecim; 1976 May 18; 92(1):1-2. PubMed ID: 1248428
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.
    Honigfeld G.
    Psychiatr Serv; 1996 Jan 18; 47(1):52-6. PubMed ID: 8925346
    [Abstract] [Full Text] [Related]

  • 15. Agranulocytosis during treatment with chlozapine.
    Idänpään-Heikkilä J, Alhava E, Olkinuora M, Palva IP.
    Eur J Clin Pharmacol; 1977 Mar 11; 11(3):193-8. PubMed ID: 856603
    [Abstract] [Full Text] [Related]

  • 16. Letter: Clozapine and agranulocytosis.
    Idänpään-Heikkilä J, Alhava E, Olkinuora M, Palva I.
    Lancet; 1975 Sep 27; 2(7935):611. PubMed ID: 51442
    [No Abstract] [Full Text] [Related]

  • 17. Clozapine and agranulocytosis.
    Senn HJ, Jungi WF, Kunz H, Pöldinger W.
    Lancet; 1977 Mar 05; 1(8010):547. PubMed ID: 65644
    [No Abstract] [Full Text] [Related]

  • 18. Clozapine: the commitment to patient safety.
    Alphs LD, Anand R.
    J Clin Psychiatry; 1999 Mar 05; 60 Suppl 12():39-42. PubMed ID: 10372610
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.